Artificial intelligence (AI) is set to revolutionize the pharmaceutical industry, offering unprecedented efficiencies in product development and manufacturing processes. By manipulating and processing vast amounts of data, AI can significantly enhance the development of new products and streamline the processes that manufacture them. This technology has already been implemented in various supporting functions such as supply chain management, information technology, finance, human resources, legal services, and compliance matters. These advancements are critical for pharmaceutical companies, which are now at the forefront of using AI to boost both profits and efficiencies in production, manufacturing, and shipment.
However, unlike many other industries, pharmaceutical, biotechnology, and medical device companies must navigate a complex landscape of legal, ethical, regulatory, and product development hurdles to ensure the safety and efficacy of new products aimed at diagnosing, treating, or preventing human diseases and disorders. This is where AI can be particularly beneficial—not only for the companies utilizing this technology and their investors but also for society at large. AI has the potential to identify and improve pharmaceutical and medical products during the development process, thereby reducing approval times and bringing life-saving products to those in need more quickly.
Click here to view the full article